ENDRA Life Sciences Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2016 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
ENDRA Life Sciences Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2016 to Q4 2023.
  • ENDRA Life Sciences Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $21.2M, a 14.2% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $21.2M +$2.63M +14.2% Dec 31, 2023 10-K 2024-03-28
Q4 2022 $18.5M +$4.71M +34% Dec 31, 2022 10-K 2024-03-28
Q4 2021 $13.8M +$2.54M +22.6% Dec 31, 2021 10-K 2023-03-16
Q4 2020 $11.3M +$3.46M +44.3% Dec 31, 2020 10-K 2022-03-30
Q4 2019 $7.82M +$1.22M +18.5% Dec 31, 2019 10-K 2021-03-25
Q4 2018 $6.6M +$2.58M +64.1% Dec 31, 2018 10-K 2020-03-26
Q4 2017 $4.02M +$219K +5.75% Dec 31, 2017 10-K 2019-03-11
Q4 2016 $3.8M Dec 31, 2016 10-K 2018-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.